DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

BIT:CPR • NL0015435975

6.738 EUR
+0.1 (+1.45%)
Last: Feb 12, 2026, 05:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

CPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 31 industry peers in the Beverages industry. CPR has only an average score on both its financial health and profitability. CPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year CPR was profitable.
  • CPR had a positive operating cash flow in the past year.
  • In the past 5 years CPR has always been profitable.
  • CPR had a positive operating cash flow in each of the past 5 years.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.51%, CPR is doing worse than 64.52% of the companies in the same industry.
  • CPR has a Return On Equity of 5.44%. This is in the lower half of the industry: CPR underperforms 67.74% of its industry peers.
  • CPR has a Return On Invested Capital of 7.03%. This is comparable to the rest of the industry: CPR outperforms 58.06% of its industry peers.
  • CPR had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 8.06%.
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROIC 7.03%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.57%, CPR is in line with its industry, outperforming 41.94% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CPR has declined.
  • The Operating Margin of CPR (21.32%) is better than 64.52% of its industry peers.
  • In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 57.55%, CPR belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CPR has been increased compared to 1 year ago.
  • The number of shares outstanding for CPR has been increased compared to 5 years ago.
  • Compared to 1 year ago, CPR has about the same debt to assets ratio.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.71 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CPR's Altman-Z score of 2.71 is fine compared to the rest of the industry. CPR outperforms 74.19% of its industry peers.
  • The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CPR (8.49) is comparable to the rest of the industry.
  • CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
  • CPR's Debt to Equity ratio of 0.64 is fine compared to the rest of the industry. CPR outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Altman-Z 2.71
ROIC/WACC1.02
WACC6.88%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • CPR has a Current Ratio of 2.32. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
  • CPR has a Current ratio of 2.32. This is amongst the best in the industry. CPR outperforms 90.32% of its industry peers.
  • A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
  • CPR has a Quick ratio of 0.91. This is amongst the best in the industry. CPR outperforms 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.91
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
  • Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
  • Looking at the last year, CPR shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
  • CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%

3.2 Future

  • Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.51% on average per year.
  • CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.25% yearly.
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 39.64, the valuation of CPR can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 77.42% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CPR to the average of the S&P500 Index (28.18), we can say CPR is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 20.68 indicates a rather expensive valuation of CPR.
  • Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 64.52% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. CPR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 39.64
Fwd PE 20.68
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 61.29% of the companies in the same industry are cheaper than CPR, based on the Enterprise Value to EBITDA ratio.
  • CPR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CPR is more expensive than 61.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.85
EV/EBITDA 13.03
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)18.12
PEG (5Y)N/A
EPS Next 2Y4.77%
EPS Next 3Y7.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.02%, CPR has a reasonable but not impressive dividend return.
  • CPR's Dividend Yield is slightly below the industry average, which is at 2.55.
  • Compared to an average S&P500 Dividend Yield of 1.80, CPR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

  • The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DAVIDE CAMPARI-MILANO NV

BIT:CPR (2/12/2026, 5:36:15 PM)

6.738

+0.1 (+1.45%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-29
Earnings (Next)03-04
Inst Owners23.2%
Inst Owner ChangeN/A
Ins Owners50.8%
Ins Owner ChangeN/A
Market Cap8.30B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts72.31
Price Target7 (3.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.76%
PT rev (3m)1.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.16%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 39.64
Fwd PE 20.68
P/S 2.7
P/FCF 25.85
P/OCF 12.72
P/B 2.24
P/tB 68.34
EV/EBITDA 13.03
EPS(TTM)0.17
EY2.52%
EPS(NY)0.33
Fwd EY4.84%
FCF(TTM)0.26
FCFY3.87%
OCF(TTM)0.53
OCFY7.86%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)18.12
PEG (5Y)N/A
Graham Number3.39
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROCE 9.58%
ROIC 7.03%
ROICexc 7.57%
ROICexgc 17.42%
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
FCFM 10.45%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Debt/EBITDA 2.97
Cap/Depr 230.39%
Cap/Sales 10.79%
Interest Coverage 6.41
Cash Conversion 81.69%
Profit Quality 159.18%
Current Ratio 2.32
Quick Ratio 0.91
Altman-Z 2.71
F-Score6
WACC6.88%
ROIC/WACC1.02
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year26.24%
EBIT Next 3Y12.26%
EBIT Next 5Y10.28%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%

DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


What is the profitability of CPR stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.


Can you provide the financial health for CPR stock?

The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 2.19% in the next year.